Jun Toyohara

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 18

Top Topics

Histone Deacetylase

Cerebral Blood Flow

Top Venues

EJNMMI radiopharmacy and chemistry

Annals of nuclear medicine

EJNMMI research

European journal of nuclear medicine and molecular imaging

This page only lists publications with an associated author ORCID identifier.

Publications

Jun Toyohara, Tetsuro Tago, Muneyuki Sakata
Process validation and preclinical development of a new PET cerebral blood flow tracer [ 11 C]MMP for initial clinical trials. EJNMMI radiopharmacy and chemistry 9 (1) (2024)
Tetsuro Tago, Jun Toyohara
Step-by-step optimisation of the radiosynthesis of the brain HDAC6 radioligand [ 18 F]FSW-100 for clinical applications. EJNMMI radiopharmacy and chemistry 9 (1) (2024)
Jun Toyohara, Tetsuro Tago, Muneyuki Sakata
Process validation and preclinical development of a new PET cerebral blood flow tracer [ 11 C]MMP for initial clinical trials. EJNMMI radiopharmacy and chemistry 9 (1) (2024)
Jun Toyohara, Tetsuro Tago, Muneyuki Sakata
Process validation and preclinical development of a new PET cerebral blood flow tracer [ 11 C]MMP for initial clinical trials. EJNMMI radiopharmacy and chemistry 9 (1) (2024)
Tetsuro Tago, Muneyuki Sakata, Masakatsu Kanazawa, Shigeyuki Yamamoto, Kenji Ishii, Jun Toyohara
Preclinical validation of a novel brain-penetrant PET ligand for visualization of histone deacetylase 6: a potential imaging target for neurodegenerative diseases. European journal of nuclear medicine and molecular imaging (2024)
Tetsuro Tago, Muneyuki Sakata, Masakatsu Kanazawa, Shigeyuki Yamamoto, Kenji Ishii, Jun Toyohara
Preclinical validation of a novel brain-penetrant PET ligand for visualization of histone deacetylase 6: a potential imaging target for neurodegenerative diseases. European journal of nuclear medicine and molecular imaging 51 (8) (2024)
Tetsuro Tago, Jun Toyohara
Step-by-step optimisation of the radiosynthesis of the brain HDAC6 radioligand [ 18 F]FSW-100 for clinical applications. EJNMMI radiopharmacy and chemistry 9 (1) (2024)
Tetsuro Tago, Jun Toyohara
Step-by-step optimisation of the radiosynthesis of the brain HDAC6 radioligand [ 18 F]FSW-100 for clinical applications. EJNMMI radiopharmacy and chemistry 9 (1) (2024)
Jun Toyohara, Muneyuki Sakata, Kei Wagatsuma, Tetsuro Tago, Kenji Ishibashi, Kenji Ishii, Philip Elsinga, Kiichi Ishiwata
Test-retest reproducibility of cerebral adenosine A2A receptor quantification using [11C]preladenant. Annals of nuclear medicine (2021)
Jun Toyohara, Muneyuki Sakata, Kenji Ishibashi, Pascalle Mossel, Masamichi Imai, Kei Wagatsuma, Tetsuro Tago, Etsuko Imabayashi, Nicola A Colabufo, Gert Luurtsema, Kenji Ishii
First clinical assessment of [18F]MC225, a novel fluorine-18 labelled PET tracer for measuring functional P-glycoprotein at the blood-brain barrier. Annals of nuclear medicine 35 (11) (2021)
Tetsuro Tago, Jun Toyohara, Kenji Ishii
Preclinical Evaluation of an 18F-Labeled SW-100 Derivative for PET Imaging of Histone Deacetylase 6 in the Brain. ACS chemical neuroscience 12 (4) (2021)
Jun Toyohara, Muneyuki Sakata, Tetsuro Tago, Nicola A Colabufo, Gert Luurtsema
Automated synthesis, preclinical toxicity, and radiation dosimetry of [18F]MC225 for clinical use: a tracer for measuring P-glycoprotein function at the blood-brain barrier. EJNMMI research 10 (1) (2020)
Jun Toyohara, Norihiro Harada, Takeharu Kakiuchi, Hiroyuki Ohba, Masakatsu Kanazawa, Tetsuro Tago, Muneyuki Sakata, Kiichi Ishiwata
Synthesis and evaluation of N-isopropyl-p-[11C]methylamphetamine as a novel cerebral blood flow tracer for positron emission tomography. EJNMMI research 10 (1) (2020)
Jun Toyohara, Hiroyuki Yamamoto, Tetsuro Tago
Searching for diagnostic properties of novel fluorine-18-labeled D-allose. Annals of nuclear medicine 33 (11) (2019)
Tetsuro Tago, Jun Toyohara
Advances in the Development of PET Ligands Targeting Histone Deacetylases for the Assessment of Neurodegenerative Diseases. Molecules (Basel, Switzerland) 23 (2) (2018)
Muneyuki Sakata, Kenji Ishibashi, Masamichi Imai, Kei Wagatsuma, Kenji Ishii, Kentaro Hatano, Kiichi Ishiwata, Jun Toyohara
Assessment of safety, efficacy, and dosimetry of a novel 18-kDa translocator protein ligand, [11C]CB184, in healthy human volunteers. EJNMMI research 7 (1) (2017)
Mayumi Okamoto, Kyosuke Naka, Kiichi Ishiwata, Isao Shimizu, Jun Toyohara
Synthesis and basic evaluation of 7α-(3-[18F]fluoropropyl)-testosterone and 7α-(3-[18F]fluoropropyl)-dihydrotestosterone. Annals of nuclear medicine 31 (1) (2016)
Jun Toyohara, Muneyuki Sakata, Kentaro Hatano, Shuichi Yanai, Shogo Endo, Kenji Ishibashi, Kei Wagatsuma, Kenji Ishii, Kiichi Ishiwata
Preclinical and first-in-man studies of [(11)C]CB184 for imaging the 18-kDa translocator protein by positron emission tomography. Annals of nuclear medicine 30 (8) (2016)